Vitamin E ve Nörolojik Hastalıklar
Özet
E vitamini, santral sinir sisteminde oksidatif stresle mücadele ederek hücre zarlarını koruyan kritik bir antioksidan ve nöroprotektif ajandır. Eksikliği durumunda özellikle denge bozuklukları, periferik nöropati ve kas koordinasyon kaybı gibi ciddi nörolojik semptomlar gelişebilmektedir. Alzheimer, Parkinson ve ALS gibi nörodejeneratif hastalıklarda E vitamini takviyesinin bilişsel gerilemeyi yavaşlatabileceği ve hücresel hasarı azaltabileceği yönünde güçlü kanıtlar bulunmaktadır. Bununla birlikte, iskemik inmeye karşı koruyucu etkileri gözlenirken, yüksek doz kullanımın bazı vakalarda hemorajik inme riskini artırabileceği de belirtilmektedir.
Vitamin E is a critical antioxidant and neuroprotective agent that protects cell membranes by combating oxidative stress in the central nervous system. Its deficiency can lead to serious neurological symptoms, particularly balance disorders, peripheral neuropathy, and loss of muscle coordination. There is strong evidence that vitamin E supplementation can slow cognitive decline and reduce cellular damage in neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. However, while its protective effects against ischemic stroke are observed, it is also noted that high-dose use may increase the risk of hemorrhagic stroke in some cases.
Referanslar
Knight JA. Reactive oxygen species and the neurodegenerative disorders. Annals of Clinical & Laboratory Science;1997; 27(1):11-25.
Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science;1993; 262(5134): 689-695. doi: 10.1126/science.790190
Martin A, Janigian D, Shukitt-Hale B, et al. Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain research;1999; 845(1): 50-59. doi.org/10.1016/S0006-8993(99)01923-X
Traber MG. Vitamin E regulatory mechanisms. Annu. Rev. Nutr.;2007;27, 347–362.
Neophytou C M, Constantinou A I. Drug delivery innovations for enhancing the anticancer potential of vitamin E isoforms and their derivatives. BioMed Res. Int.; 2015; 584862. doi.org/10.1155/2015/584862
Sookwong P, Nakagawa K, Yamaguchi Y, et al. Tocotrienol distribution in foods: estimation of daily tocotrienol intake of Japanese population. J. Agric. Food Chem.;2010; (58): 3350–3355. doi.org/10.1021/jf903663k
Schmolz L, Birringer M, Lorkowski S, et al. Complexity of vitamin E metabolism. World J. Biol. Chem. 2016; (7): 14–43. doi: 10.4331/wjbc.v7.i1.14
Traber MG, Kayden HJ. Preferential incorporation of alphatocopherol vs gamma-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 1989; (49): 517–526.
Traber MG, Ramakrishnan R, Kayden HJ. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. Proc. Natl. Acad. Sci. U. S. A.;1994;(91): 10005–10008. doi.org/10.1073/pnas.91.21.10005
Kono N, Arai H. Intracellular transport of fat-soluble vitamins A and E. Traffic; 2015;(16): 19–34. doi.org/10.1111/tra.12231
Hosomi A, Arita M, Sato Y, et al. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett.; 1997;(409): 105–108. doi.org/10.1016/S0014-5793(97)00499-7
Sontag T J., Parker R S. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002;(277):25290–25296. doi.org/10.1074/jbc.M201466200
Clement M, Dinh L, Bourre JM. Uptake of dietary RRR-alpha- and RRR-gamma-tocopherol by ´nervous tissues, liver and muscle in vitamin-E-deficient rats. Biochim. Biophys. Acta; 1995;(1256):175–80. doi.org/10.1016/0005-2760(95)00019-9
Dror DK, Allen LH. Vitamin E deficiency in developing countries. Food and nutrition bulletin;2011;32(2):124-143. doi.org/10.1177/156482651103200206
Khadangi F, Azzi A.Vitamin E–the next 100 years. IUBMB life;2019; 71(4): 411-415. doi.org/10.1002/iub.1990
Gomez-Pomar E, Hatfield E, Garlitz K, et al. Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia. Am J Perinatol.; 2018;35(3):305-310. doi.org/10.1055/s-0037-1607283
Southam E, Thomas PK, King RH, et al. Experimental vitamin E deficiency in rats. Morphological and functional evidence of abnormal axonal transport secondary to free radical damage. Brain; 1994;114(2):915–36. doi.org/10.1093/brain/114.2.915
Goss-SampsonMA, Kriss A,Muller DP. A longitudinal study of somatosensory, brainstem auditory and peripheral sensory-motor conduction during vitamin E deficiency in the rat. J. Neurol. Sci.;1990;(100):79–84. doi.org/10.1016/0022-510X(90)90016-G
Yokota T, Igarashi K, Uchihara T, et al. Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. USA;2001; (98):15185–90. doi.org/10.1073/pnas.26145609
Gohil K, Schock BC, Chakraborty AA, et al. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in α-tocopherol transfer protein. Free Radic. Biol. Med.;2003;(35):1343–54.doi.org/10.1016/S08915849(03)005094
Hyland S, Muller D, Hayton S, et al. Cortical gene expression in the vitamin E-deficient rat: possible mechanisms for the electrophysiological abnormalities of visual and neural function. Ann. Nutr. Metab.;2006;(50):433–41.doi.org/10.1159/000094635
Pillai SR, Traber MG, Kayden HJ, et al. Concomitant brainstem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J. Neurol. Sci.;1994;(123):64–73.doi.org/10.1016/0022-510X(94)90205-4
Gohil K, Vasu VT, Cross CE. Dietary α-tocopherol and neuromuscular health: Search for optimal dose and molecular mechanisms continues! Mol. Nutr. Food Res.; 2010;(54):693–709. doi.org/10.1002/mnfr.200900575
Finosh GT, Jayabalan M. Reactive oxygen species—control and management using amphiphilic biosynthetic hydrogels for cardiac applications. Adv. Biosci. Biotechnol.;2013;(4): 1134–1146. doi:10.4236/abb.2013.412150
Birben E, Sahiner UM, Sackesen C, et al. Oxidative stress and antioxidant defense. World Allergy Organ. J.; 2012;(5): 9–19.
Fraga C G, Oteiza P I, Galleano, M. Plant bioactives and redox signaling: (−)-Epicatechin as a paradigm. Mol. Aspects Med.;2018; (61): 31–40. doi.org/10.1016/j.mam.2018.01.007
Kozarski M, Klaus A, Jakovljevic D, et al. Antioxidants of edible mushrooms. Molecules;2015; (20),19489–19525. doi.org/10.3390/molecules201019489
Poitelon Y, Kopec AM, Belin S. Myelin fat facts: an overview of lipids and fatty acid metabolism. Cells;2020;(9): 812. doi.org/10.3390/cells9040812
Abou Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci.;2006; (7): 207–219.
Cheignon C, Tomas M, Bonnefont Rousselot D, et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol.;2017; 14: 450–464. doi.org/10.1016/j.redox.2017.10.014
Grimm M, Mett J, Hartmann T. The impact of vitamin E and other fat soluble vitamins on Alzheimer s disease. Int J Mol Sci.;2016; (17): 1785. doi.org/10.3390/ijms17111785
Ricciarelli R, Argellati F, Pronzato MA, et al. Vitamin E and neurodegenerative diseases. Mol Aspects Med.;2007; (28): 591–606. doi.org/10.1016/j.mam.2007.01.004
Salminen A, Ojala J, Kauppinen A, et al. Inflammation in Alzheimer’s disease: amyloid β oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol.;2009; (87): 181–194. doi.org/10.1016/j.pneurobio.2009.01.001
Cassidy L, Fernandez F, Johnson JB et al. Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics. Complement Ther Med.;2020; (49): 102294.
Simioni C, Zauli G, Martelli AM, et al. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget;2018; (9): 17181–17198.
Aggarwal BB, Sundaram C, Prasad S, et al. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol.;2010; (80):1613–1631. doi.org/10.1016/j.bcp.2010.07.043
Maniam S, Mohamed N, Shuid AN, et al. Palm tocotrienol exerted better antioxidant activities in bone than α-Tocopherol. Basic Clin. Pharmacol. Toxicol.; 2008; (103):55–60. doi.org/10.1111/j.1742-7843.2008.00241.x
Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Rad. Biol. Med.;2007; (43): 4–15. doi.org/10.1016/j.freeradbiomed.2007.03.024
Zingg JM. Vitamin E: A role in signal transduction. Annu. Rev. Nutr.;2015: (35): 135–173. doi.org/10.1146/annurev-nutr-071714-034347
Reiter E, Jiang Q, Christen S. Anti-inflammatory properties of α- andγ-tocopherol. Mol. Asp. Med.; 2007;28, 668–691. doi.org/10.1016/j.mam.2007.01.003
Lee CY, Man-Fan Wan J. Vitamin E Supplementation Improves Cell-Mediated Immunity and Oxidative Stress of Asian Men and Women. J. Nutr.; 2000;130, 2932–2937. doi.org/10.1093/jn/130.12.2932
De la Fuente M, Hernanz A, Guayerbas N, et al. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic. Res.; 2008,42, 272–280. doi.org/10.1080/10715760801898838
Montano Velazquez BB, Jauregui-Renaud K, Banuelos Arias Adel C, et al. Vitamin E effects on nasal symptoms and serum specific IgE levels in patients with perennial allergic rhinitis. Ann. Allergy Asthma Immunol.; 2006,96, 45–50. doi.org/10.1016/S1081-1206(10)61039-3
Wolvers DA, van Herpen-Broekmans WM, Logman MH, et al. Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: A randomized placebo-controlled study. Nutr. J.; 2006,5, 28–35.
Hemila H, Kaprio J. Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C. Am. J. Epidemiol.; 2009,169, 946–953. doi.org/10.1093/aje/kwn413
Hemila H, Kaprio J. Vitamin E may affect the life expectancy of men, depending on dietary vitamin Cintake and smoking. Age Ageing; 2011,40, 215–220. doi.org/10.1093/ageing/afq178
Jiang Z, Yin X, Jiang Q. Natural forms of vitamin E and 13′-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively. J. Immunol.;2011,186, 1173–1179. doi.org/10.4049/jimmunol.1002342
Tasinato A, Boscoboinik D, Bartoli GM, et al. d-α-Tocopherol Inhibition of Vascular Smooth Muscle Cell Proliferation Occurs at Physiological Correlates with Protein Kinase C Inhibition and Is Independent of Its Antioxidant properties. Proc. Natl. Acad. Sci.;1995,92, 12190–12194. doi.org/10.1073/pnas.92.26.1219
Muller DPR, Lloyd JK, Wolff OH. Vitamin E and neurological function. Lancet; 1983;1:225–8. doi.org/10.1002/mnfr.200900460
Selkoe DJ. Defining molecular targets to prevent Alzheimer disease. Arch. Neurol. 2005;62, 192–195. doi:10.1001/archneur.62.2.192
Tanzi RE, Bertram L. New frontiers in Alzheimer’s disease genetics. Neuron; 2001; 32, 181–184. doi.org/10.1016/S0896-6273(01)00476-7
Yatin SM, Aksenov M, Butterfield DA. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer’s disease. Neurochem. Res.; 1999; 24, 427–435.
Butterfield DA, Castegna A, Drake J, et al. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr. Neurosci.; 2002; 5, 229–239. doi.org/10.1080/10284150290028954
Yokota T, Toshiaki S,Takanari G, et al.Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann. Neurol.;1997;41, 826–832. doi.org/10.1002/ana.410410621
Garcia-Alloza M, Dodwell SA., Meyer-Luehmann M, et al. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J. Neuropathol. Exp. Neurol. 2006; 65, 1082–1089. doi.org/10.1097/01.jnen.0000240468.12543.af
Rota C, Rimbach G, Minihane AM, et al. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implication for its neuroprotective properties. Nutr. Neurosci.;2005; 8, 21–29. doi.org/10.1080/10284150400027123
Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Arch. Neurol.;2002; 59, 1125–1132. doi:10.1001/archneur.59.7.1125
Engelhart MJ, Geerlings MI, Ruitenberg A. Dietary intake of antioxidants and risk of Alzheimer disease. Jama;2002; 287, 3223– 3229. doi:10.1001/jama.287.24.3223
Bhimani R. Understanding the burden on caregivers of people with Parkinson’s: A scoping review of the literature. Rehab Res Pract.; 2014; 718527. doi.org/10.1155/2014/718527
Pretzer-Aboff I, Galik E, Resnick B. Parkinson’s disease: barriers and facilitators to optimizing function. Rehabil Nurs.; 2009; 34: 54–60. doi.org/10.1002/j.2048-7940.2009.tb00249.x
Coupland KG, Mellick GD, Silburn PA, et al. DNA methylation of the MAPT gene in Parkinson’s disease cohorts and modulation by vitamin E in vitro. Mov Disord; 2014; 29: 1606–1614. doi.org/10.1002/mds.25784
Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins: vitamins E and C, beta carotene, and other carotenoids. Ann N Y Acad Sci.; 1992; 669: 7–20.
İçer M, Arslan N, Karadağ G. Effects of vitamin E on neurodegenerative diseases: An update. Acta Neurobiologiae Experimentalis; 2021; 81.
Scheider W, Hershey L, Vena J, et al. Dietary antioxidants and other dietary factors in the etiology of Parkinson’s disease. Mov Disord; 1997; 12: 190–196. doi.org/10.1002/mds.870120209
Miyake Y, Fukushima W, Tanaka K, et al. Dietary intake of antioxidant vitamins and risk of Parkinson’s disease: a case–control study in Japan. Eur J Neurol.; 2011; 18: 106–113. doi.org/10.1111/j.1468-1331.2010.03088.x
Hughes KC, Gao X, Kim IY, et al. Intake of antioxidant vitamins and risk of Parkinson’s disease. Mov Disord; 2016; 31: 1909–1914. doi.org/10.1002/mds.26819
Yang F, Wolk A, Håkansson N, et al. Dietary antioxidants and risk of Parkinson’s disease in two population-based cohorts. Mov Disord; 2017; 32: 1631–1636. doi.org/10.1002/mds.27120
Voko Z, Hollander M, Hofman A, et al. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology;2003; 61: 1273–1275. doi.org/10.1212/01.WNL.0000090458.67821.A3
Del Rio D, Agnoli C, Pellegrini N, et al. Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large italian cohort. J Nutr.; 2010; 141: 118–123. doi.org/10.3945/jn.110.125120
Uesugi S, Ishihara J, Iso H, et al. Dietary intake of antioxidant vitamins and risk of stroke: the Japan Public Health Center–based Prospective Study. Eur J Clin Nutrit.; 2017; 71: 1179–1185.
Cheng P, Wang L, Ning S, et al. Vitamin E intake and risk of stroke: a meta analysis. Br J Nutr.;2018; 120: 1181–1188. doi.org/10.1017/S0007114518002647
Leppälä JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke;1999; 30: 2535–2540. doi.org/10.1161/01.STR.30.12.2535
Miyamoto K, Shiozaki M, Shibata M, et al. Very-high-dose α-tocopherol supplementation increases blood pressure and causes possible adverse central nervous system effects in stroke prone spontaneously hypertensive rats. J Neurosci Res.;2009; 87: 556–566. doi.org/10.1002/jnr.21851
Oskarsson B, Gendron TF, Staff NP. Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc.; 2018; 93: 1617–1628. doi.org/10.1016/j.mayocp.2018.04.007
Gunnarsson LG, Bodin L. Amyotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta analysis. Int Environ Res Public Health;2018; 15: 2371. doi.org/10.3390/ijerph15112371
Patel BP, Hamadeh MJ. Nutritional and exercise based interventions in the treatment of amyotrophic lateral sclerosis. Clin Nutr.;2009; 28: 604–617. doi.org/10.1016/j.clnu.2009.06.002
Sienko DG, Davis JP, Taylor JA, et al. Amyotrophic lateral sclerosis: a case control study following detection of a cluster in a small Wisconsin community. Arch Neurol.;1990; 47: 38–41. doi:10.1001/archneur.1990.00530010046017
Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology;1976; 26: 167–167. doi.org/10.1212/WNL.26.2.167
Pierce Ruhland R, Patten, B. Repeat study of antecedent events in motor neuron disease. Ann Clin Res.;1981; 13: 102–107.
Longnecker M, Kamel F, Umbach D, et al. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology;2000; 19: 210–216. doi.org/10.1159/000026258
Ascherio A, Weisskopf MG, O’Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol.;2005; 57: 104–110. doi.org/10.1002/ana.20316
Veldink JH, Kalmijn S, Groeneveld GJ, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry;2007; 78: 367–371.doi.org/10.1136/jnnp.2005.083378
Asl RS, Shariatmadari F, Sharafi M, et al. Dietary fish oil supplemented with vitamin E improves quality indicators of rooster cold stored semen through reducing lipid peroxidation. Cryobiology;2018;(84):15–19. doi.org/10.1016/j.cryobiol.2018.08.008
Pedersen WA, Fu W, Keller JN, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol.;1998; 44: 819–824. doi.org/10.1002/ana.410440518
Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol.;1996; 39: 147–157. doi.org/10.1002/ana.410390203
Ascherio A, Weisskopf MG, O’Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol.;2005; 57: 104–110. doi.org/10.1002/ana.20316
Galbussera A, Tremolizzo L, Brighina L, et al. Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow up case series study. Neurol Sci.;2006; 27: 190–193. doi.org/10.1007/s10072-006-0668-x
Freedman MD, Kuncl RW, Weinstein SJ, et al. Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener;2013; 14: 246–251. doi.org/10.3109/21678421.2012.745570
Iwasaki Y, Ikeda K, Kinoshita M. Vitamin A and E levels are normal in amyotrophic lateral sclerosis. J Neurol Sci.;1995;132: 193–194. doi.org/10.1016/0022-510X(95)00145-R
De Bustos F, Jimenez Jimenez F, Molina J, et al. Cerebrospinal fluid levels of alpha tocopherol in amyotrophic lateral sclerosis. J Neural Transm.;1998; 105: 703–708. doi.org/10.1007/s007020050089
